HIGHER MELPHALAN EXPOSURE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL FOR MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT

被引：6
|
作者：
Shaw, P. J. [1 ,2 ]
Nath, C. E. [1 ]
Nivison-Smith, I [3 ]
Joshua, D. E. [2 ,4 ]
Kerridge, I. H. [2 ,5 ]
Presgrave, P. [6 ]
Tiley, C. R. [7 ]
Kwan, Y. L. [8 ]
Trotman, J. [2 ,8 ]
机构：
[1] Childrens Hosp Westmead, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] St Vincents Hosp, Sydney, NSW 2010, Australia
[4] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[5] Royal N Shore Hosp, Sydney, NSW, Australia
[6] Wollongong Hosp, Wollongong, NSW, Australia
[7] Gosford Hosp, Gosford, England
[8] Concord Hosp, Sydney, NSW, Australia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2011.12.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [41] Therapy with thalidomide enhances overall survival after autologous PBSC transplant for multiple myeloma.
    Brinker, B
    Waller, EK
    Langston, AA
    Redei, I
    Smith, KJ
    Bucur, SZ
    Winton, E
    Lyles, R
    Heffner, LT
    Lonial, S
    BLOOD, 2002, 100 (11) : 178A - 178A
  • [42] A Randomized Phase I Study of Melphalan and Bortezomib for Autologous Transplant in Myeloma
    Kaufman, J. L.
    Lonial, S.
    Sinha, R.
    Torre, C.
    Langston, A. A.
    Lechowicz, M. J.
    Flowers, C.
    McMillan, S.
    Renfroe, H.
    Heffner, L. T.
    Waller, E. K.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S60 - S60
  • [43] Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome
    Kumar, Lalit
    Sahoo, Ranjit Kumar
    Kumar, Sudhir
    Baa, Annie K. K.
    Tansir, Ghazal
    Pathak, Neha
    Malik, Prabhat S. S.
    Sharma, Om Dutt
    Mathew, Anisha
    Jha, Ankit
    Gupta, Ritu
    Sharma, Atul
    Biswas, Ahitagni
    Kumar, Rakesh
    Thulkar, Sanjay
    Malik, Soumyaranjan
    Dutt, Ashish
    AIIMS Myeloma Grp
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 378 - 387
  • [44] Outcome of High Dose Melphalan with Autologous Hematopoietic Stem Cell Transplant In Myeloma Associated with AL Amyloidosis
    Parmar, Simrit
    Khan, Mubeen
    Rondon, Gabriela
    Shah, Nina
    Bashir, Qaiser
    Tung, Shawndeep
    Shah, Jatin J.
    Weber, Donna
    Orlowski, Robert Z.
    Giralt, Sergio
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BLOOD, 2010, 116 (21) : 995 - 995
  • [45] EVALUATION OF OVERALL SURVIVAL ASSOCIATED WITH CHANGE IN DOSING OF BORTEZOMIB, MELPHALAN, AND PREDNISONE REGIMEN IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A REAL-WORLD STUDY
    Mehra, M.
    Potluri, R.
    Lam, A.
    Slavcev, M.
    VALUE IN HEALTH, 2019, 22 : S113 - S113
  • [46] Outcomes of Multiple Myeloma Patients With Prior Solid Tumors Undergoing an Autologous Transplant
    Pasvolsky, Oren
    Milton, Denai
    Rafaeli, Natalie
    Tanner, Mark
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Tang, Guilin
    Mohamedi, Ali
    Aljawai, Yosra
    Lee, Hans
    Patel, Krina
    Kebriaei, Partow
    Thomas, Sheeba
    Orlowski, Robert
    Shpall, Elizabeth
    Champlin, Richard
    Qazilbash, Muzaffar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S239 - S239
  • [47] Secondary malignancies in patients undergoing autologous hematopoietic cell transplant for multiple myeloma
    Sakellari, I.
    Mallouri, D.
    Bousiou, Z.
    Kaliou, M.
    Lalayanni, C.
    Papathanasiou, M.
    Constantinou, V.
    Papaioannou, G.
    Sotiropoulos, D.
    Batsis, I.
    Fytili, C.
    Geroukis, T.
    Katodritou, E.
    Vadikoliou, C.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S472 - S472
  • [48] Secondary Malignancies in Patients Undergoing Autologous Hematopoietic Cell Transplant for Multiple Myeloma
    Vadikoliou, Chrysanthi
    Bousiou, Zoi
    Kaliou, Maria
    Athanasiadou, Anastasia
    Sakellari, Ioanna
    Lalayanni, Chrysavgi
    Anagnostopoulos, Achilleas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E112 - E112
  • [49] Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response
    Pasvolsky, Oren
    Abid, Muhammad Bilal
    Milton, Denai R.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Jatoi, Asiya
    Khan, Hina N.
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Tang, Guilin
    Siddiqui, Umer
    Aljawai, Yosra
    Kebriaei, Partow
    Lee, Hans C.
    Patel, Krina K.
    Gaballa, Mahmoud R.
    Thomas, Sheeba K.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Qazilbash, Muzaffar H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2025,
  • [50] Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell Transplant
    Alattar, Mona Lisa
    Patel, Prapti
    Anderson, L. D., Jr.
    Collins, Robert H.
    Zhang, Song
    Naina, Harris
    Kwong, Chi Yin
    Vusirikala, Madhuri
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S127 - S128
12345